Literature DB >> 15232656

Diagnosis of suspected Alzheimer's disease is improved by automated analysis of regional cerebral blood flow.

Bich-Ngoc-Thanh Tang1, Satoshi Minoshima, Jean George, Annie Robert, Christian Swine, Patrice Laloux, Thierry Vander Borght.   

Abstract

PURPOSE: Accurate diagnosis of Alzheimer's disease (AD), the most common form of dementia, remains difficult. In order to assess whether fully automated stereotactic surface projection (3D-SSP) presentation contributes to the diagnosis of AD by single-photon emission computed tomography (SPECT), we investigated the diagnostic accuracy of transaxial display with and without 3D-SSP analysis as well as the correlation between cerebral perfusion in different cortical areas and the mini mental score (MMS).
METHODS: Seventy-two patients referred because of cognitive impairment were included in the study. According to the National Institute of Neurological and Communicative Disorders and Stroke (NINCDS) and the Alzheimer's disease and Related Disorders Association (ADRDA) criteria, 27 patients were diagnosed as having probable AD while 45 were classified as non-AD patients. 3D-SSP was used to quantify the regional cerebral blood flow (rCBF) acquired from SPECT imaging.
RESULTS: Compared with the transaxial section presentation alone, 3D-SSP presentation improved the area under the receiver operating curve (p<0.05) as well as intra-observer (k=0.73 vs 0.88) and inter-observer (k=0.50 vs 0.84) reproducibility. Upon normalisation of regional to thalamic activity, multiple regression analysis revealed a strong correlation between the MMS and rCBF in the right parietal cortex (p=0.002).
CONCLUSION: Addition of 3D-SSP to the transaxial section display of ECD-SPECT studies improves the reproducibility and the diagnostic performance in respect of AD in patients with cognitive impairment and provides a valid tool for assessment of the severity of cortical perfusion abnormalities in such patients.

Entities:  

Mesh:

Year:  2004        PMID: 15232656     DOI: 10.1007/s00259-004-1597-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  47 in total

1.  Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease.

Authors:  Karl Herholz; Helge Schopphoff; Mathias Schmidt; Rüdiger Mielke; Wolfgang Eschner; Klemens Scheidhauer; Harald Schicha; Wolf-Dieter Heiss; Klaus Ebmeier
Journal:  J Nucl Med       Date:  2002-01       Impact factor: 10.057

2.  Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.

Authors:  K A Jobst; L P Barnetson; B J Shepstone
Journal:  Int Psychogeriatr       Date:  1998-09       Impact factor: 3.878

Review 3.  Similarities between Alzheimer's disease and vascular dementia.

Authors:  Raj Kalaria
Journal:  J Neurol Sci       Date:  2002-11-15       Impact factor: 3.181

4.  Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake.

Authors:  Darius Soonawala; Tania Amin; Klaus P Ebmeier; J Douglas Steele; Nadine J Dougall; Jonathan Best; Octave Migneco; Flavio Nobili; Klemens Scheidhauer
Journal:  Neuroimage       Date:  2002-11       Impact factor: 6.556

5.  Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series.

Authors:  A Lim; D Tsuang; W Kukull; D Nochlin; J Leverenz; W McCormick; J Bowen; L Teri; J Thompson; E R Peskind; M Raskind; E B Larson
Journal:  J Am Geriatr Soc       Date:  1999-05       Impact factor: 5.562

6.  Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias.

Authors:  O L Lopez; I Litvan; K E Catt; R Stowe; W Klunk; D I Kaufer; J T Becker; S T DeKosky
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

7.  FDG PET imaging in patients with pathologically verified dementia.

Authors:  J M Hoffman; K A Welsh-Bohmer; M Hanson; B Crain; C Hulette; N Earl; R E Coleman
Journal:  J Nucl Med       Date:  2000-11       Impact factor: 10.057

8.  Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type.

Authors:  B A Pickut; R A Dierckx; A Dobbeleir; K Audenaert; K Van Laere; A Vervaet; P P De Deyn
Journal:  Psychiatry Res       Date:  1999-04-26       Impact factor: 3.222

9.  [A systematic genetic-epidemiologic family study of patients with Alzheimer disease--experience with the MIRAGE study in Germany].

Authors:  N Lautenschlager; E J Foley; M Haupt; R Zimmer; L A Farrer; A Kurz
Journal:  Z Gerontol       Date:  1994 Sep-Oct

10.  Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis.

Authors:  S Minoshima; K A Frey; N L Foster; D E Kuhl
Journal:  J Comput Assist Tomogr       Date:  1995 Jul-Aug       Impact factor: 1.826

View more
  7 in total

1.  A new automated method for analysis of rCBF-SPECT images based on the active-shape algorithm: normal values.

Authors:  Douglas Hägerström; David Jakobsson; Erik Stomrud; Ann-Margret Andersson; Erik Ryding; Elisabet Londos; Lennart Minthon; Ingmar Rosén; Lars Edenbrandt
Journal:  Clin Physiol Funct Imaging       Date:  2011-11-08       Impact factor: 2.273

2.  Quantitative Analysis of Torso FDG-PET Scans by Using Anatomical Standardization of Normal Cases from Thorough Physical Examinations.

Authors:  Takeshi Hara; Tatsunori Kobayashi; Satoshi Ito; Xiangrong Zhou; Tetsuro Katafuchi; Hiroshi Fujita
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

3.  Automated identification of dementia using medical imaging: a survey from a pattern classification perspective.

Authors:  Chuanchuan Zheng; Yong Xia; Yongsheng Pan; Jinhu Chen
Journal:  Brain Inform       Date:  2015-12-21

4.  Voxel-wise correlations between cognition and cerebral blood flow using arterial spin-labeled perfusion MRI in patients with Alzheimer's disease: a cross-sectional study.

Authors:  Tomohiro Kaneta; Omi Katsuse; Takamasa Hirano; Matsuyoshi Ogawa; Ayako Shihikura-Hino; Keisuke Yoshida; Toshinari Odawara; Yoshio Hirayasu; Tomio Inoue
Journal:  BMC Neurol       Date:  2017-05-15       Impact factor: 2.474

5.  Localizing Epileptic Foci Before Surgery in Patients With MRI-Negative Refractory Epilepsy Using Statistical Parameter Mapping and Three-Dimensional Stereotactic Surface Projection Based on 18F-FDG PET.

Authors:  Hailing Zhou; Wei Zhang; Zhiqiang Tan; Ziqing Zhou; Ying Li; Shaojuan Zhang; Lingling Zhang; Jiefeng Gan; Huanhua Wu; Yongjin Tang; Yong Cheng; Xueying Ling; Qiang Guo; Hao Xu
Journal:  Front Bioeng Biotechnol       Date:  2022-01-05

6.  Direct comparison study between FDG-PET and IMP-SPECT for diagnosing Alzheimer's disease using 3D-SSP analysis in the same patients.

Authors:  Takashi Nihashi; Hiroshi Yatsuya; Kazumasa Hayasaka; Rikio Kato; Shoji Kawatsu; Yutaka Arahata; Katsushige Iwai; Akinori Takeda; Yukihiko Washimi; Kumiko Yoshimura; Kanako Mizuno; Takashi Kato; Shinji Naganawa; Kengo Ito
Journal:  Radiat Med       Date:  2007-07-27

7.  Confirmation of 123I-FP-CIT SPECT Quantification Methods in Dementia with Lewy Bodies and Other Neurodegenerative Disorders.

Authors:  Daniela D Maltais; Lennon G Jordan; Hoon-Ki Min; Toji Miyagawa; Scott A Przybelski; Timothy G Lesnick; Robert R Reichard; Dennis W Dickson; Melissa E Murray; Kejal Kantarci; Bradley F Boeve; Val J Lowe
Journal:  J Nucl Med       Date:  2020-03-20       Impact factor: 11.082

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.